Casey Orvin

Chief Commercial Officer

Alcanza Clinical Research

Casey has a long and exemplary career history in pharmaceutical research site services and currently serves as Chief Commercial Officer for Alcanza, a rapidly growing site network focused on underrepresented patient populations. Prior to joining Alcanza, he was CCO for CenExel and was responsible for the company’s robust growth over the last several years. Casey also served as President of the Society for Clinical Research Sites (SCRS), a global organization representing over 10,000 clinical research sites in 47 countries within the pharmaceutical industry and currently serves on the SCRS Leadership Council.

Casey began his career in 2001 leading a large pharmaceutical research site network, Research Solutions. In 2007, he was recruited to join Clinical Research Advantage/Radiant as Executive Vice President of Business Development and successfully led a network of over 75 research sites conducting clinical trials for pharmaceuticals, vaccines, and medical devices. Under Casey’s leadership, several crucial partnerships were formed with major pharmaceutical companies which fueled the company’s rapid growth both geographically and within the medical community. Casey facilitated the acquisition of two competitors securing the company’s spot as what was at the time the largest clinical research site network in the US. In 2015, Casey and the executive team at Radiant merged with Synexus, a division of PPD. With Casey’s guidance, Synexus continued to expand to 215 global clinical sites in 4 continents and over 15 countries. Casey also served as SVP of Pharmaceutical Relationships at StudyKik, a full-service patient recruitment and retention technology company.

Casey is passionate about representing the site voice within the industry while ensuring every research patient’s journey is a positive one. As a thought leader in the industry, he is regularly invited to be a keynote speaker and panelist and is often quoted by the leading publications covering the clinical research landscape.

In 2020, he was recognized in PharmaVoice as one of the 100 Most Inspiring People in the industry.

Speaker Sessions